https://pharmadog.xyz/news/473499 pharmadog en 2026-09-29T19:37:50.000Z Webinar: From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesis https://pharmadog.xyz/news/473475 pharmadog en 2026-09-29T19:05:29.000Z Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech https://pharmadog.xyz/news/473371 pharmadog en 2026-09-29T18:34:00.000Z Beam Therapeutics sues YolTech and Serapha Bio over alleged theft of base editing trade secrets https://pharmadog.xyz/news/473184 pharmadog en 2026-09-29T17:54:41.000Z Beam Therapeutics sues former scientist over alleged IP theft to launch Chinese biotech YolTech https://pharmadog.xyz/news/473139 pharmadog en 2026-09-29T17:00:06.000Z PhRMA appoints former House Majority Leader Eric Cantor as new president and CEO https://pharmadog.xyz/news/473015 pharmadog en 2026-09-29T16:14:43.000Z FDA nominee Heidi Overton’s confirmation won’t be voted on before the midterm elections https://pharmadog.xyz/news/472779 pharmadog en 2026-09-29T15:52:00.000Z Novo to pay Hengrui up to $2.6 billion for rights to weekly obesity pill HRS-1596 https://pharmadog.xyz/news/472715 pharmadog en 2026-09-29T15:15:18.000Z SK pharmteco commits over $200 million to expand CDMO infrastructure, adding 100 jobs over five years https://pharmadog.xyz/news/473450 pharmadog en 2026-09-29T15:05:00.000Z Canadian $5M accelerated clinical trial program cuts start-up to 45 days https://pharmadog.xyz/news/472547 pharmadog en 2026-09-29T14:46:04.000Z Ascletis pursues oral IL-17A inhibitor for psoriasis as Invivyd readies COVID-19 filing https://pharmadog.xyz/news/472591 pharmadog en 2026-09-29T14:32:24.000Z Anthropic joins ARPA‑H clinical AI moonshot and will host a closed‑door health‑care event https://pharmadog.xyz/news/472548 pharmadog en 2026-09-29T14:23:49.000Z UniQure shares tumble as Huntington's gene therapy shows reduced benefit over time https://pharmadog.xyz/news/472571 pharmadog en 2026-09-29T14:13:37.000Z Roche drops anti-myostatin obesity drug after mid-stage trial shows limited weight loss https://pharmadog.xyz/news/472549 pharmadog en 2026-09-29T14:11:43.000Z Oura cancels planned IPO citing market uncertainty despite strong demand https://pharmadog.xyz/news/472423 pharmadog en 2026-09-29T13:52:51.000Z AstraZeneca commits $2 billion to partner Summit Therapeutics on bispecific cancer antibody https://pharmadog.xyz/news/472403 pharmadog en 2026-09-29T13:45:07.000Z AstraZeneca invests $2 billion in Summit Therapeutics to fund Phase 3 trials of ivonescimab https://pharmadog.xyz/news/472424 pharmadog en 2026-09-29T13:25:06.000Z Novo to pay up to $2.6 billion for rights to Hengrui’s experimental weekly obesity pill https://pharmadog.xyz/news/473114 pharmadog en 2026-09-29T13:22:00.000Z Enanta cuts 37 jobs as it pivots toward immunology and awaits key antiviral trial readouts https://pharmadog.xyz/news/472379 pharmadog en 2026-09-29T13:16:55.000Z ARCH Venture Partners and Population Health Partners launch China-based sleep-disorder startup Somnivera https://pharmadog.xyz/news/472380 pharmadog en 2026-09-29T13:00:58.000Z Fresenius Kabi partners with Waltz Health to sell biosimilars directly to employer health plans https://pharmadog.xyz/news/472381 pharmadog en 2026-09-29T13:00:49.000Z Former Spark co-founder Steven Altschuler launches new immune-resetting biotech https://pharmadog.xyz/news/472443 pharmadog en 2026-09-29T13:00:00.000Z ai3Bio raises $48 million to develop T-helper cell-targeted immune-reset therapies https://pharmadog.xyz/news/472275 pharmadog en 2026-09-29T12:49:00.000Z AstraZeneca puts $2 billion into Summit Therapeutics and partners to test ivonescimab with its oncology pipeline https://pharmadog.xyz/news/472235 pharmadog en 2026-09-29T12:33:27.000Z Novo Nordisk licenses weekly oral obesity peptide from Hengrui in up to $2.6 billion deal https://pharmadog.xyz/news/472255 pharmadog en 2026-09-29T12:02:41.000Z Study finds blocking T cells entry into brain slows neurodegeneration in mice https://pharmadog.xyz/news/472043 pharmadog en 2026-09-29T11:45:14.000Z AI health startup Ortet launches with $500M backing from former Genentech AI team https://pharmadog.xyz/news/472087 pharmadog en 2026-09-29T11:05:00.000Z UniQure’s gene therapy still slows Huntington’s disease after four years, but benefit declines https://pharmadog.xyz/news/472044 pharmadog en 2026-09-29T11:04:17.000Z Novo pays $300 million upfront to license Hengrui’s weekly oral GLP-1/GIP weight-loss drug https://pharmadog.xyz/news/472045 pharmadog en 2026-09-29T11:00:34.000Z Swedish biotech AnaCardio secures $70.9M Series B to advance heart failure drug https://pharmadog.xyz/news/471875 pharmadog en 2026-09-29T10:28:58.000Z BioNTech to shut three German manufacturing sites after sale talks fall through https://pharmadog.xyz/news/472522 pharmadog en 2026-09-29T09:29:00.000Z uniQure shares tumble 41% after Huntington’s gene therapy misses primary endpoint https://pharmadog.xyz/news/471477 pharmadog en 2026-09-29T08:30:00.000Z CMS ends automatic Medicare bonuses for FDA breakthrough devices https://pharmadog.xyz/news/471475 pharmadog en 2026-09-29T08:30:00.000Z MAHA Institute pushes for broader health data sharing to aid research on chronic disease and autism https://pharmadog.xyz/news/471476 pharmadog en 2026-09-29T08:30:00.000Z Sociologist finds vaccine-hesitant parents make logical choices, not anti-science https://pharmadog.xyz/news/471479 pharmadog en 2026-09-29T08:30:00.000Z Child health crisis threatens US national security, authors warn https://pharmadog.xyz/news/471478 pharmadog en 2026-09-29T08:30:00.000Z Midterm elections could reshape drug pricing, Medicaid funding and research support, industry leaders warn https://pharmadog.xyz/news/471480 pharmadog en 2026-09-29T08:30:00.000Z SNAP cuts risk increasing child separations, advocates warn https://pharmadog.xyz/news/471119 pharmadog en 2026-09-29T06:00:00.000Z Curium gains FDA nod for Bexlutry as it eyes challenge to Novartis radioligand therapies https://pharmadog.xyz/news/471574 pharmadog en 2026-09-29T03:51:00.000Z Novo Nordisk signs $2.6 billion deal with China's Hengrui for oral GLP-1/GIP candidate https://pharmadog.xyz/news/471406 pharmadog en 2026-09-29T03:07:00.000Z AstraZeneca invests $2 billion in Summit Therapeutics to advance PD-1xVEGF bispecific ivonescimab with ADC combos https://pharmadog.xyz/news/469979 pharmadog en 2026-09-29T00:47:27.000Z FDA approves Egetis Therapeutics' Emcitate for rare X linked disease shortening life expectancy to 35 years https://pharmadog.xyz/news/473549 pharmadog en 2026-09-29T00:00:00.000Z Recon: FDA approves Egetis’ Emcitate for rare genetic disease; Novo buys rights to Chinese weight-loss pill in $2.6B deal https://pharmadog.xyz/news/469535 pharmadog en 2026-09-28T22:22:39.000Z AstraZeneca invests $2 billion for stake in Summit Therapeutics to back its cancer drug https://pharmadog.xyz/news/469618 pharmadog en 2026-09-28T21:43:18.000Z FDA approves Emcitate for peripheral thyrotoxicosis in patients with MCT8 deficiency https://pharmadog.xyz/news/469411 pharmadog en 2026-09-28T21:07:09.000Z Study finds toxic metal exposure persists months after Maui wildfires https://pharmadog.xyz/news/469619 pharmadog en 2026-09-28T21:00:01.000Z FDA to review and potentially overhaul PMTA rules amid lawsuit and illicit market concerns https://pharmadog.xyz/news/469243 pharmadog en 2026-09-28T20:45:43.000Z Merck pulls Recarbrio antibiotic from U.S. market, raising concerns over superbug resistance https://pharmadog.xyz/news/469031 pharmadog en 2026-09-28T19:01:13.000Z Adicet Bio reports early CAR-T therapy improves lupus symptoms, plans pivotal trial as shares fall https://pharmadog.xyz/news/468863 pharmadog en 2026-09-28T18:50:33.000Z Mirum reports Phase 3 success for its acquired hepatitis D therapy https://pharmadog.xyz/news/468651 pharmadog en 2026-09-28T17:55:51.000Z Trump administration seeks Supreme Court stay on gender-affirming care restrictions in federal prisons https://pharmadog.xyz/news/468607 pharmadog en 2026-09-28T17:41:21.000Z White House seeks data on U.S. manufacturing of 86 essential medicines https://pharmadog.xyz/news/472354 pharmadog en 2026-09-28T16:25:00.000Z ai3Bio raises $48 million to develop T-cell targeting therapy for autoimmune disease https://pharmadog.xyz/news/468503 pharmadog en 2026-09-28T16:11:00.000Z Kodiak Sciences' Phase 3 eye drug data beats Regeneron’s Eylea, shares double https://pharmadog.xyz/news/468504 pharmadog en 2026-09-28T15:52:00.000Z Adicet's off-the-shelf CAR-T shows 50% kidney response in early lupus trial https://pharmadog.xyz/news/468271 pharmadog en 2026-09-28T15:45:19.000Z Nonprofits launch ultra-rare immune disease gene therapy Waskyra at $3.25 million price https://pharmadog.xyz/news/468272 pharmadog en 2026-09-28T15:22:04.000Z Scynexis secures $200M+ BARDA contract for investigational antifungal SCY-247 https://pharmadog.xyz/news/468273 pharmadog en 2026-09-28T15:19:38.000Z Kodiak Sciences reports Phase 3 success for Zenkuda, matching Eylea in wet AMD https://pharmadog.xyz/news/468295 pharmadog en 2026-09-28T15:11:01.000Z Kodiak Sciences' zenkuda and tabirafusp-ted match Eylea in Phase 3, sending stock up 166% https://pharmadog.xyz/news/468147 pharmadog en 2026-09-28T14:55:21.000Z Rising health insurance premiums and a private equity hospital chain's shift to nonprofit highlight bleak outlook for US healthcare costs https://pharmadog.xyz/news/472670 pharmadog en 2026-09-28T14:26:00.000Z Sierra Nevada Cheese Company recalls all Graziers raw milk cheeses over possible E. coli O26:H11 contamination https://pharmadog.xyz/news/468103 pharmadog en 2026-09-28T14:06:16.000Z Roche halts development of muscle-preserving obesity drug and returns program to Chugai https://pharmadog.xyz/news/468104 pharmadog en 2026-09-28T14:00:16.000Z Merck licenses KRAS G12D inhibitor from Tao Hu for $400 million upfront https://pharmadog.xyz/news/467959 pharmadog en 2026-09-28T13:57:13.000Z Mirum receives FDA approval for Atebrioz, third therapy for ultra-rare bone disease FOP https://pharmadog.xyz/news/467960 pharmadog en 2026-09-28T13:50:27.000Z Merck signs up to $2.13 billion deal with SciBrunch for preclinical KRAS inhibitor SPR2015 https://pharmadog.xyz/news/467979 pharmadog en 2026-09-28T13:40:32.000Z AbbVie’s once-daily Parkinson’s pill receives FDA approval https://pharmadog.xyz/news/467961 pharmadog en 2026-09-28T13:33:58.000Z BioSpace report examines factors driving employee engagement in life sciences firms https://pharmadog.xyz/news/467980 pharmadog en 2026-09-28T13:06:52.000Z GLP-1 drugs shift from obesity treatment to lifestyle products, prompting setbacks for Merck and Daiichi https://pharmadog.xyz/news/467831 pharmadog en 2026-09-28T12:52:00.000Z Merck, Daiichi end plans to seek speedy approval of lung cancer ADC https://pharmadog.xyz/news/467811 pharmadog en 2026-09-28T12:22:37.000Z Trump administration pulls nearly $1 billion from HHS programs for immigrants and diversity https://pharmadog.xyz/news/467791 pharmadog en 2026-09-28T12:16:02.000Z AbbVie receives FDA approval for Parkinson’s drug Juvmo, a Cerevel acquisition asset https://pharmadog.xyz/news/467515 pharmadog en 2026-09-28T11:15:56.000Z Merck and Daiichi Sankyo pull accelerated approval request for lung cancer ADC https://pharmadog.xyz/news/467491 pharmadog en 2026-09-28T11:13:26.000Z Merck and Daiichi withdraw FDA accelerated approval filing for B7-H3 ADC in small cell lung cancer https://pharmadog.xyz/news/468246 pharmadog en 2026-09-28T11:05:00.000Z Roche halts obesity antibody emugrobart after negative phase 2 interim readout https://pharmadog.xyz/news/467910 pharmadog en 2026-09-28T09:37:00.000Z Mirum's Phase 3 Trial Shows Brelovitug Achieves Primary Endpoint in Hepatitis D Study https://pharmadog.xyz/news/467911 pharmadog en 2026-09-28T09:30:00.000Z Scynexis secures $214 million BARDA contract to advance oral and IV antifungal SCY-247 https://pharmadog.xyz/news/467912 pharmadog en 2026-09-28T09:00:00.000Z Tolerance Bio signs up to $560M deal for anti-IL-33 drug from Tanabe https://pharmadog.xyz/news/467220 pharmadog en 2026-09-28T09:00:00.000Z Operational talent, not just science, will drive next biopharma breakthroughs https://pharmadog.xyz/news/467219 pharmadog en 2026-09-28T09:00:00.000Z Azurity urges simpler medicines for children to reduce daily burdens on families https://pharmadog.xyz/news/468418 pharmadog en 2026-09-28T08:51:00.000Z Precision Neuroscience raises $250M in Series D to expand brain-computer interface program https://pharmadog.xyz/news/467913 pharmadog en 2026-09-28T08:37:00.000Z Kodiak Sciences' eye disease drug matches Eylea in Phase 3, sending stock soaring https://pharmadog.xyz/news/467032 pharmadog en 2026-09-28T08:30:00.000Z AI tools that aid vaccine design could also accelerate creation of bioweapons, warns former White House Covid adviser https://pharmadog.xyz/news/467031 pharmadog en 2026-09-28T08:30:00.000Z Novo Nordisk rebrands GLP-1 therapy Wegovy as weight-loss product, positioning it as lifestyle drug https://pharmadog.xyz/news/467033 pharmadog en 2026-09-28T08:30:00.000Z Researchers identify previously unseen structure in the human heart https://pharmadog.xyz/news/467916 pharmadog en 2026-09-28T08:11:00.000Z Merck signs $400 million deal with China’s SciBrunch for KRAS G12D preclinical candidate https://pharmadog.xyz/news/467742 pharmadog en 2026-09-28T08:06:00.000Z Sofinnova Partners raises €82 million to expand medtech creation strategy in Europe and U.S. https://pharmadog.xyz/news/466507 pharmadog en 2026-09-28T05:01:00.000Z Regenerative medicine requires diagnostics and product characterization beyond stem cell basics https://pharmadog.xyz/news/466231 pharmadog en 2026-09-28T04:02:00.000Z Ultragenyx gains FDA approval for Fayuvi, a Sanfilippo syndrome A therapy, easing impact of recent Angelman setback https://pharmadog.xyz/news/466232 pharmadog en 2026-09-28T04:01:00.000Z Biopharma chases new immunology targets as Humira and Dupixent set high bar https://pharmadog.xyz/news/466962 pharmadog en 2026-09-28T03:40:00.000Z Merck and Daiichi withdraw lung cancer ADC filing after FDA says data insufficient https://pharmadog.xyz/news/469612 pharmadog en 2026-09-28T00:00:00.000Z FDA advises early engagement and error prevention for BLA submissions, says CBER expert https://pharmadog.xyz/news/469610 pharmadog en 2026-09-28T00:00:00.000Z FDA offers guidance for smoother BLA submissions and outlines biosimilar review changes https://pharmadog.xyz/news/469611 pharmadog en 2026-09-28T00:00:00.000Z Indian government approves monitoring plan for adverse events in organ and tissue transplantation products https://pharmadog.xyz/news/468513 pharmadog en 2026-09-28T00:00:00.000Z FDA CDER chief says expanding generic GLP-1 drugs is top priority to cut American costs https://pharmadog.xyz/news/469609 pharmadog en 2026-09-28T00:00:00.000Z FDA proposes new BsUFA IV commitment letter to streamline biosimilar reviews